Congo to Receive 70,000 Doses of FDA-Approved Ebola Vaccine

— But it's not known if it will protect against the virus responsible for the current outbreak

August 20, 2026

• 2 min read

Congo will receive 70,000 doses of the rVSVΔG-ZEBOV-GP (Ervebo) vaccine, which has been effective in past Ebola outbreaks, the World Health Organization (WHO) and partners said Thursday, announcing a step seen as a major boost to efforts to contain what officials have described as the fastest Ebola outbreak in history.

The single-dose live-attenuated vaccine is licensed for use against Zaire virus, but not for Bundibugyo virus, which is responsible for the current outbreak that has so far killed 2,476 people out of the 5,208 confirmed cases.

Congo to Receive 70,000 Doses of FDA-Approved Ebola Vaccine

Other newsrooms on this story

Related reading

Congo to receive 70,000 doses of Ervebo Ebola vaccine, which was effective in…

Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective…

DR Congo receives 70,000 Ebola vaccine doses for outbreak response | Africanews

DRC to receive 70,000 doses of Ebola vaccine used in past outbreaks

Ebola-hit DR Congo gets 70,000 doses of Ervebo vaccine: WHO

Congo set to receive 70,000 Ervebo vaccines to contain Ebola outbreak, WHO says